Therese Liechtenstein

Therese Liechtenstein is a Senior Investment Director at M Ventures with a strong background in biotech investments, having held various leadership roles in the industry. She has successfully invested in companies like DISCO Pharmaceuticals, Anavo Therapeutics, Altoida, Future Fertility, Theolytics, and FoRx Therapeutics, showcasing her expertise in nurturing and supporting innovative startups in the biotech sector. Liechtenstein's career highlights include serving as a Board Member for multiple companies, such as ReproNovo, DISCO Pharmaceuticals GmbH, Theolytics, Anavo Therapeutics BV, FoRx Therapeutics, and Future Fertility, demonstrating her strategic leadership and commitment to driving growth and success in the biotech industry.